Venoarterial Extracorporeal Membrane Oxygenation for Acute Massive Pulmonary Embolism: a Meta-Analysis and Call to Action

Venoarterial extracorporeal membrane oxygenation (ECMO) has been used to treat acute massive pulmonary embolism (PE) patients. However, the incremental benefit of ECMO to standard therapy remains unclear. Our meta-analysis objective is to compare in-hospital mortality in patients treated for acute m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaso, Elona Rrapo, Pan, Jonathan A., Salerno, Michael, Kadl, Alexandra, Aldridge, Chad, Haskal, Ziv J., Kennedy, Jamie L. W., Mazimba, Sula, Mihalek, Andrew D., Teman, Nicholas R., Giri, Jay, Aronow, Herbert D., Sharma, Aditya M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288068/
https://www.ncbi.nlm.nih.gov/pubmed/34282541
http://dx.doi.org/10.1007/s12265-021-10158-0
Descripción
Sumario:Venoarterial extracorporeal membrane oxygenation (ECMO) has been used to treat acute massive pulmonary embolism (PE) patients. However, the incremental benefit of ECMO to standard therapy remains unclear. Our meta-analysis objective is to compare in-hospital mortality in patients treated for acute massive PE with and without ECMO. The National Library of Medicine MEDLINE (USA), Web of Science, and PubMed databases from inception through October 2020 were searched. Screening identified 1002 published articles. Eleven eligible studies were identified, and 791 patients with acute massive PE were included, of whom 270 received ECMO and 521 did not. In-hospital mortality was not significantly different between patients treated with vs. without ECMO (OR = 1.24 [95% CI, 0.63–2.44], p = 0.54). However, these findings were limited by significant study heterogeneity. Additional research will be needed to clarify the role of ECMO in massive PE treatment. GRAPHICAL ABSTRACT: [Figure: see text]

Ejemplares similares